Cleared Traditional

K131720 - HIVOX SELF ADHESIVE ELECTRODE GEL PADS

K131720 is an FDA 510(k) clearance for HIVOX SELF ADHESIVE ELECTRODE GEL PADS, manufactured by Hivox Biotek, Inc.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 408-day FDA review.

K131720 · Hivox Biotek, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2014
Decision
408d
Days
Class 2
Risk

K131720 is an FDA 510(k) clearance for the HIVOX SELF ADHESIVE ELECTRODE GEL PADS. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Hivox Biotek, Inc. (New Taipei City, TW). The FDA issued a Cleared decision on July 25, 2014 after a review of 408 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Hivox Biotek, Inc. devices

FDA 510(k) Submission Details - K131720

510(k) Number K131720 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 12, 2013
Decision Date July 25, 2014
Days to Decision 408 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
259d slower than avg
Panel avg: 149d · This submission: 408d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 338
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K131720.
CUTANEOUS ELECTRODES
K142099 · Bio Protech, Inc. · Nov 2014
GARMENT ELECTRODES
K141076 · Shenzhen Dongdixin Technology Co., Ltd. · Nov 2014
WEARABLE THERAPY GARMENTS
K141342 · Axiobionics, LLC · Nov 2014
AXON-BUS PROSTHETIC SYSTEM
K123795 · Otto Bock Austria · Jun 2014
SKINTACT
K140340 · Leonhard Lang GmbH · May 2014
PALS PLATINUM NEUROSTIMULATION ELECTRODES
K132422 · Axelgaard Mfg. Co., Ltd. · Feb 2014